Quick Answer
Emmaus Life Sciences, Inc. reported Stockholders Equity of -$63.61 million for the year ending 2025.
- Emmaus Life Sciences, Inc. showed a decrease of -12.6% in Stockholders Equity from 2024 to 2025.
- This data is from Emmaus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$507.6 thousand | Q2 2014: -$1.35 million | Q4 2014: -$2.55 million | Q2 2015: -$3.64 million | Q4 2015: -$6.65 million | Q1 2016: -$6.61 million | Q2 2016: -$7.47 million | Q4 2016: $768.8 thousand | Q1 2017: $526.8 thousand | Q2 2017: -$953.1 thousand | Q3 2017: $4.55 million | Q1 2018: $1.84 million | Q2 2018: $3.11 million | Q3 2018: $4.02 million | Q4 2018: -$21.71 million | Q1 2019: -$32.31 million | Q2 2019: -$43.16 million | Q3 2019: -$12.17 million | Q1 2020: -$4.73 million | Q2 2020: -$14.02 million | Q3 2020: -$6.37 million | Q1 2021: -$12.68 million | Q2 2021: -$9.38 million | Q3 2021: -$15.10 million | Q1 2022: -$22.30 million | Q2 2022: -$34.64 million | Q3 2022: -$37.59 million | Q1 2023: -$37.36 million | Q2 2023: -$35.03 million | Q3 2023: -$36.33 million | Q1 2024: -$53.64 million | Q2 2024: -$57.01 million | Q3 2024: -$53.78 million | Q1 2025: -$58.60 million | Q2 2025: -$55.70 million | Q3 2025: -$59.49 million.
- Over the full 19 years of available data (2010 to 2025), Emmaus Life Sciences, Inc.'s Stockholders Equity has declined by 1,412.9%.
- Historical annual values: Fiscal year 2025: -$63.61 million | Fiscal year 2024: -$56.48 million | Fiscal year 2023: -$47.76 million | Fiscal year 2022: -$34.09 million | Fiscal year 2021: -$21.45 million | Fiscal year 2020: -$5.16 million | Fiscal year 2019: -$11.05 million | Fiscal year 2019: -$12.25 million | Fiscal year 2018: -$21.71 million | Fiscal year 2018: $4.02 million | Fiscal year 2017: $18.29 million | Fiscal year 2017: $4.55 million | Fiscal year 2016: -$1.06 million | Fiscal year 2015: -$4.84 million | Fiscal year 2014: -$1.76 million | Fiscal year 2013: -$2.16 million | Fiscal year 2012: -$13.07 million | Fiscal year 2011: -$11.42 million | Fiscal year 2010: -$4.20 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: